Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00513773 · ClinicalTrials.gov registry record
Inflammation and Risk Prediction in Patients With Abdominal Aortic Aneurysm
A clinical trial of Aortic Aneurysm, Abdominal, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- 14
- Enrollment target
- 1
- Study location
NCT00513773 is a study of Aortic Aneurysm, Abdominal that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 14 participants, below the 153-participant average among 8 other Aortic Aneurysm, Abdominal trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00513773, a study of Aortic Aneurysm, Abdominal, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- 14 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to better understand the role of inflammation in the pathophysiology of abdominal aortic aneurysm. In this study we hope to show better ways of predicting risk in this condition by using a combination of FDG-PET with CT.
Conditions Studied
Study Locations (1)
Tennessee
- Vanderbilt University Medical Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2008-07 |
| Est. Completion | 2014-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00513773
The ClinicalTrials.gov registry entry for NCT00513773 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 153-participant average among 8 other Aortic Aneurysm, Abdominal trials with a reported enrollment target (91% lower). The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Aortic Aneurysm, Abdominal appearing as the primary indexed condition, and to 0 interventions.
NCT00513773 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.
Frequently Asked Questions
What is clinical trial NCT00513773 about?
NCT00513773 is a clinical study titled "Inflammation and Risk Prediction in Patients With Abdominal Aortic Aneurysm". The purpose of this study is to better understand the role of inflammation in the pathophysiology of abdominal aortic aneurysm. In this study we hope to show better ways of predicting risk in this condition by using a combination of FDG-PET with CT.
What is the current status of trial NCT00513773?
This trial is currently completed. The enrollment target is 14 participants. The study started on 2008-07. Estimated completion is 2014-02.
What conditions does trial NCT00513773 study?
This clinical trial studies the following conditions: Aortic Aneurysm, Abdominal.
Who is sponsoring clinical trial NCT00513773?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00513773 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aortic Aneurysm, Abdominal
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
ShOrt neCK AAA RAndomized Trial - ESAR and FEVAR: SOCRATES
RECRUITING · NA
-
Comparison of EVAR and ESAR for Infrarenal Aortic Aneurysms With a Wide Proximal Neck
RECRUITING · NA
-
Clinical Outcomes of Patients Treated With Open Surgical Repair for Complex Aortic Aneurysms
RECRUITING
-
AAA-SHAPE Pivotal Trial: Abdominal Aortic Aneurysm Sac Healing and Prevention of Expansion
RECRUITING · NA
-
Liposomal Bupivacaine/Bupivacaine in Rectus Sheath Blocks Versus Ropivacaine in Rectus Sheath Blocks And Catheters
RECRUITING · Phase 4
-
Zenith® Fenestrated+ Clinical Study
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.